IPM valued at Rs 6357 crores in August 2013
10 therapies have outgrown the IPM growth
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
’We are expecting around 8000 plus delegates for 65th IPC’
In the run up to the 65th Indian Pharmaceutical Congress to be held in New Delhi, Atul Nasa, President, Indian Pharmaceutical…
Indore to host 2nd edition of PharmaTech Expo 2013
Event to be held from October 6-8, 2013, to share ideas about the recent technologies in pharmaceuticals
DIA to host 8th Annual Conference: The New Clinical Research Environment in India: Implications…
The New Clinical Research Environment in India: Implications and Opportunities conference to be held in Bangalore on October…
FEAPM and CIPI join PHARMA Pro&Pack Expo 2014 exhibition
Special pavilion for analytical instruments products and services
IPCA executive council meeting held at New Delhi
Reviews the preparation of 65th Indian Pharmaceutical Congress and other issues related to the event
Better than Statins
Even as the statin market faces generic erosion, pharma companies are trying to figure out novel drugs and fixed dose combinations…
’Patient adherence team spending more than doubled from 2009 to 2011’
M Neelam Kachhap speakes to Manish Gupta, Chief Executive Officer, Indegene Lifesystems Bangalore, to know more about the rising…
UKTI signs MoU with ABLE
Will aim at combining UK's heritage and leadership in the area of healthcare and life sciences and India's emerging and thriving…
Competition intensifies as pharma companies race to launch type II diabetes drugs
New Frost & Sullivan report analysis which products will eventually succeed and why, in the race against time
Avesthagen signs license agreement with AvestaDHATM
Through the non-exclusive agreement, Avesthagen stands to earn $30 million over the next decade
Novo Nordisk launches basal insulin for adult patients with type I and type II diabetes
To be available in India soon
US FDA accepts Boehringer Ingelheims supplemental new drug application
To be used for use of dabigatran etexilate mesylate in deep vein thrombosis and pulmonary embolism
Bilcare starts field validation studies of its nonClonableID technology
Developed in collaboration with CSIR, the system aims to secure the pharma supply chain as well as improve patient compliance
Zandu Ayurveda launches its first clinic at Nature Cure & Yoga Centre in Kolkata
Plans to launch more clinics in other select cities
Lupin receives US FDA approval for generic rifadin capsules
Is indicated for the treatment of all forms of tuberculosis
Expansion of product offerings with focus on cancer therapeutics drives M&A activity
India market sees no deals in August ‘13